Surveillance of rEspiratory viruses iN healThcare and anImal workers in the NethErLands
- Conditions
- airway infectionrespiratory infection10047438
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
18 years old and above
Exclusion Criteria
none
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint is the early detection of respiratory virus infections<br /><br>that occur in HCW or AW, and the identification of the causative agent during<br /><br>the observation period. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study endpoints include the assessment of local and systemic<br /><br>virus-specific immune responses, risk factors, data on infection kinetics, and<br /><br>genetic variation between causative viruses after a respiratory tract infection<br /><br>or vaccination against respiratory viruses. </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does the SENTINE trial (NL-OMON56919) assess molecular mechanisms of respiratory virus transmission in occupational groups?
What comparative effectiveness data exist for standard-of-care antiviral treatments in occupational respiratory virus infections?
Which biomarkers are associated with increased risk of respiratory virus infection in high-exposure workers per NL-OMON56919?
What adverse health outcomes are linked to occupational respiratory virus exposure in the SENTINE trial (NL-OMON56919)?
What antiviral compounds or vaccines are relevant to viruses monitored in the NL-OMON56919 observational study?